SUBSCRIBE
SUBSCRIBE
Sruthi Balakrishnan

Sruthi S. Balakrishnan

Freelance writer

Sruthi S. Balakrishnan is a freelance academic editor, science writer and fact-checker based in Santa Barbara, California. She can be reached at sruthisb@sciscriber.com.

syringe in a vial with a radioactive symbol against a background of antibodies
ADCs
rADCs Could Take Cancer Treatment ‘Magic Bullet’ to a New Level
Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors.
October 21, 2024
 · 
6 min read
 · 
Sruthi S. Balakrishnan
Pictured: Fractured time and melting clock/Taylor
Drug Development
Psychosis: The Other Big Alzheimer’s Therapeutic Target
While disease-modifying therapies largely steal the spotlight in Alzheimer’s drug development, several companies are working to solve this less-discussed but disruptive facet of the illness.
March 27, 2024
 · 
7 min read
 · 
Sruthi S. Balakrishnan
Pictured: a conceptual drawing of the small extrac
Drug Development
Exosome Therapeutics Are Paving a Path to Clinical Readiness
Exosomes show potential to treat myriad conditions, including cancer and inflammation, but experts are divided on whether the therapies are ready for the limelight.
March 4, 2024
 · 
6 min read
 · 
Sruthi S. Balakrishnan
Syringe resting on top of a vaccine vial, with more vaccine bottles in the background
Drug Development
5 Cancer Vaccines to Watch in 2024
BioSpace takes a deep dive into five investigational therapeutic cancer vaccines that have recently shown efficacy in difficult-to-treat indications.
November 16, 2023
 · 
6 min read
 · 
Sruthi S. Balakrishnan
Illustration of a clipboard with check marks, and
Career Advice
In Hiring, Some Companies Move Toward Focus on Skills Over Experience
Newer hiring models based on skills applicants have learned and their general potential for growth could avoid the drawbacks of relying on degrees and experience.
November 7, 2023
 · 
5 min read
 · 
Sruthi S. Balakrishnan
A child flexes his arms for a doctor in a clinic a
Policy
How Companies Are Upping Diversity Among Clinical Trial Participants
After the FDA released draft guidance on increasing diversity in clinical trials, companies have been left to figure out the details. Here’s what experts say is working.
October 17, 2023
 · 
7 min read
 · 
Sruthi S. Balakrishnan